HealthCareEquipment.org


Status: In Stock

Neonatal Phototherapy System


Description:

Neonatal Phototherapy System by Avalon Biomedical (Shenzhen) Limited

The Neonatal Phototherapy System devised by Avalon Biomedical (Shenzhen) Limited is a specialized medical equipment, created to provide the necessary light therapy treatment to newborns suffering from jaundice.

This sophisticated device plays a crucial role in the treatment of neonatal hyperbilirubinemia or neonatal jaundice, a common condition in newborns marked by high levels of bilirubin in the blood. The Neonatal Phototherapy System aids in breaking down the excess bilirubin into a form that is easier for a baby's liver to process and eliminate.

One of the key advantages of the Neonatal Phototherapy System is its capability to deliver precise light at the correct intensity and wavelength, targeting specifically the bilirubin molecule. This ensures a smooth, effective, and safe breakdown of bilirubin.

Furthermore, the device boasts an adjustable irradiance level and effective coverage area, ensuring comprehensive treatment. The system is designed to be user-friendly with an easily adjustable height and angle, allowing care providers to alter settings to suit the individual needs of every newborn.

With safety and comfort in mind, the Neonatal Phototherapy System offers quiet operation, gentle light, and a soft mattress, reducing the stress on the newborns. It is equipped with a reliable temperature monitoring system ensuring optimal and secure conditions for the newborn throughout the treatment duration.

It's important to note that this product is designed for use under the supervision of professional healthcare providers in a medical setting. Avalon Biomedical (Shenzhen) Limited continues to prioritize patient care through its innovative solutions.


Primary Use:

Neonatal Phototherapy System: A Critical Tool in Newborn Care

The Neonatal Phototherapy System represents a significant advancement in infant care technology. This device has been primarily designed to aid in the treatment of conditions


How It Works:

Understanding Neonatal Phototherapy Systems

Renowned for its essential role in the medical field, the Neonatal Phototherapy System serves as an indispensable unit in neonatology. Catering to the needs of the most delicate patients - newborns, especially those requiring specific care, the device facilitates the treatment of certain conditions like Neonatal Jaundice, a common physiological occurrence in newborns. Functionality
The aim of the Neonatal Phototherapy System is to degrade unconjugated bilirubin levels in the newborn's body, providing effective treatment for jaundice. It does this by using a particular wavelength of light able to fragment bilirubin enough that it becomes water-soluble. Thus, the baby's liver no longer has the sole responsibility of processing it. System Composition
It consists of an incubator, fitted with LED or fluorescent lights overhead. These lights radiate a spectrum (blue/green) corresponding to the absorption peak of bilirubin. Higher-intensity lights are generally more efficient in lowering bilirubin concentration. The light intensity is adjustable, depending on varying bilirubin levels, ensuring treatment is responsive to the patient's particular condition. A substantial percentage of the emitted light spectrum is in the range that is active for effective phototherapy, making these systems incredibly efficient. Operational Safety
These systems are also designed with the safety of the neonate in mind. The lights generate minimal heat, to prevent any potential thermal stress for the infant. Protective eyewear is typically used to shield the newborn's eyes from direct light exposure. Moreover, the system includes built-in sensors to provide real-time feedback, to monitor and adjust treatment as necessary. Pioneered as a key tool in the management of neonatal jaundice, a Neonatal Phototherapy System has been critical in effectively treating the condition and improving patient outcomes while minimizing the risk of potential complications. Its use contributes significantly to reducing the jaundice-associated morbidity rates amongst neonates, thereby affirming its importance in the neonatology landscape.

Manufacturer:

Avalon Biomedical (Shenzhen) Limited


Status: In Stock


Are you the owner or manufacturer of this device? Need to update anything on this page or get in touch with us? Click here.

×

Owner/Manufacturer Registration

Thank you for your submission!

We will get in touch with you shortly.